Swiss National Bank
CCXI

Swiss National Bank’s ChemoCentryx, Inc. CCXI Stock Holding History

Swiss National Bank’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-135,100
Closed -$6.98M – 2779
2022
Q3 		$6.98M Buy
135,100
+3,100
+2% +$128K 0.01% 1080
2022
Q2 		$3.27M Buy
132,000
+16,100
+14% +$355K ﹤0.01% 1587
2022
Q1 		$2.91M Buy
115,900
+8,200
+8% +$230K ﹤0.01% 1801
2021
Q4 		$3.92M Buy
107,700
+900
+0.8% +$31.6K ﹤0.01% 1629
2021
Q3 		$1.83M Hold
106,800
– – ﹤0.01% 2114
2021
Q2 		$1.43M Sell
106,800
-3,900
-4% -$96.1K ﹤0.01% 2301
2021
Q1 		$5.67M Buy
110,700
+1,700
+2% +$102K ﹤0.01% 1380
2020
Q4 		$6.75M Buy
109,000
+10,900
+11% +$624K ﹤0.01% 1167
2020
Q3 		$5.38M Buy
98,100
+7,000
+8% +$377K ﹤0.01% 1135
2020
Q2 		$5.24M Buy
91,100
+17,600
+24% +$958K ﹤0.01% 1117
2020
Q1 		$2.95M Buy
73,500
+1,100
+2% +$46.7K ﹤0.01% 1213
2019
Q4 		$2.86M Buy
72,400
+18,000
+33% +$316K ﹤0.01% 1516
2019
Q3 		$369K Buy
54,400
+7,300
+15% +$54.8K ﹤0.01% 2427
2019
Q2 		$438K Buy
47,100
+5,600
+13% +$64.8K ﹤0.01% 2452
2019
Q1 		$576K Buy
41,500
+3,100
+8% +$35.5K ﹤0.01% 2325
2018
Q4 		$419K Hold
38,400
– – ﹤0.01% 2411
2018
Q3 		$485K Hold
38,400
– – ﹤0.01% 2427
2018
Q2 		$506K Buy
+38,400
New +$459K ﹤0.01% 2441
2014
Q2 		– Sell
-18,900
Closed -$125K – 2557
2014
Q1 		$125K Hold
18,900
– – ﹤0.01% 2466
2013
Q4 		$109K Hold
18,900
– – ﹤0.01% 2471
2013
Q3 		$105K Buy
18,900
+8,100
+75% +$87.6K ﹤0.01% 2447
2013
Q2 		$153K Buy
+10,800
New +$140K ﹤0.01% 2416

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's CCXI Position: Q4 2022 in Review

Swiss National Bank sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 135,100 shares — an estimated $6.98M sold.

Swiss National Bank first reported a position in CCXI in Q2 2013 and held it in 22 quarters. The position peaked at $6.98M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Swiss National Bank reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Swiss National Bank sold 135,100 ChemoCentryx, Inc. shares in Q4 2022, an estimated $6.98M.
  • Swiss National Bank first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 22 quarters.
  • Swiss National Bank's ChemoCentryx, Inc. position peaked at $6.98M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.